Literature DB >> 25672258

Blood transfusion in primary total shoulder arthroplasty: incidence, trends, and risk factors in the United States from 2000 to 2009.

Devon J Ryan1, Hiroyuki Yoshihara2, Daisuke Yoneoka3, Joseph D Zuckerman1.   

Abstract

BACKGROUND: Total shoulder arthroplasty (TSA) may be associated with substantial blood loss, and some patients require perioperative blood transfusion. Possible blood transfusion methods include predonated autologous blood transfusion, perioperative autologous blood transfusion, and allogeneic blood transfusion (ALBT). The purposes of the present study were to assess the incidence and recent trends over time of blood transfusion in TSA and analyze patient and hospital characteristics that affect the risk of ALBT.
METHODS: This study used national hospital discharge data from the National Inpatient Sample between 2000 and 2009. The data were used to generate the overall blood transfusion rate, and linear regression was used to assess trends in transfusion patterns over time. Logistic regression analysis was performed to analyze which patient and hospital characteristics independently influence the likelihood that a given patient undergoes ALBT.
RESULTS: The overall blood transfusion rate (ie, the proportion of patients who received at least 1 transfusion of any kind) was 6.7%. This rate increased over time, from 4.9% in 2000 to 7.1% in 2009 (P < .001). Risk factors associated with ALBT included age, gender, race, insurance status, hospital region, and hospital annual caseload.
CONCLUSIONS: The increase in overall blood transfusion rate in TSA found in the present study may be related to factors specific to TSA, such as the introduction of reverse total shoulder arthroplasty during the study period. A variety of patient and hospital characteristics contribute to the risk of undergoing ALBT.
Copyright © 2015 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  National Inpatient Sample; Total shoulder arthroplasty; blood transfusion

Mesh:

Year:  2015        PMID: 25672258     DOI: 10.1016/j.jse.2014.12.016

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  16 in total

1.  Risk Factors for Transfusions Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis.

Authors:  Elizabeth Salt; Amanda T Wiggins; Mary Kay Rayens; Katelyn Brown; Kate Eckmann; Andrew Johannemann; Raymond D Wright; Leslie J Crofford
Journal:  J Clin Rheumatol       Date:  2018-12       Impact factor: 3.517

2.  Drain Use is Associated with Increased Odds of Blood Transfusion in Total Shoulder Arthroplasty: A Population-Based Study.

Authors:  Jimmy J Chan; Carl M Cirino; Hsin-Hui Huang; Jashvant Poeran; Madhu Mazumdar; Bradford O Parsons; Shawn G Anthony; Leesa M Galatz; Paul J Cagle
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

3.  Topical and Intravenous Tranexamic Acid Are Equivalent in Decreasing Blood Loss in Total Shoulder Arthroplasty.

Authors:  Matthew Budge
Journal:  J Shoulder Elb Arthroplast       Date:  2019-05-30

4.  Risk factors for postoperative blood transfusion after shoulder arthroplasty.

Authors:  Kyle J Kopechek; Travis L Frantz; Joshua S Everhart; Richard Samade; Julie Y Bishop; Andrew S Neviaser; Gregory L Cvetanovich
Journal:  Shoulder Elbow       Date:  2021-01-20

5.  Differences in total blood loss and transfusion rate between different indications for shoulder arthroplasty.

Authors:  Dominik Malcherczyk; Juliane Hack; Antonio Klasan; Asma Abdelmoula; Thomas J Heyse; Brandon Greene; Bilal F El-Zayat
Journal:  Int Orthop       Date:  2018-08-03       Impact factor: 3.075

Review 6.  Inconclusive evidence for the efficacy of tranexamic acid in reducing transfusions, postoperative infection or hematoma formation after primary shoulder arthroplasty: A meta-analysis with trial sequential analysis.

Authors:  Jorge Rojas; Uma Srikumaran; Edward G McFarland
Journal:  Shoulder Elbow       Date:  2020-01-13

Review 7.  Tranexamic acid use to decrease blood loss in primary shoulder and elbow replacement: A systematic review and meta-analysis.

Authors:  Richard L Donovan; Jonny R Varma; Michael R Whitehouse; Ashley W Blom; Setor K Kunutsor
Journal:  J Orthop       Date:  2021-03-18

8.  Tranexamic acid use is associated with lower transfusion rates in shoulder arthroplasty patients with preoperative anaemia.

Authors:  T Bradly Clay; A Sayo Lawal; Thomas W Wright; Matthew Patrick; Aimee M Struk; Kevin W Farmer; Joseph J King
Journal:  Shoulder Elbow       Date:  2019-04-10

9.  Tranexamic acid decreases blood loss in shoulder arthroplasty: A meta-analysis.

Authors:  Bin-Feng Yu; Guo-Jing Yang; Qi Li; Liang-le Liu
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 10.  Efficiency and safety of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A systematic review and meta-analysis.

Authors:  Chuan-Xiu Sun; Lu Zhang; Li-Dong Mi; Guang-Yu Du; Xue-Gang Sun; Sheng-Wei He
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.